Oral Oncology
Volume 39, Issue 5 , Pages 476-482 , July 2003

Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan

Received 22 November 2002 ,Accepted 13 December 2002.

References 

  1. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994;79(4):573–582
  2. MacLachlan TK, Sang N, Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors (implications in cell cycle control and cancer). Crit Rev Eukaryot Gene Expr. 1995;5(2):127–156
  3. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol. 1995;147(3):545–560
  4. Brechot C. Oncogenic activation of cyclin, A. Current Opinion Genet Dev. 1993;3(1):11–18
  5. Rosenberg AR, Zindy F, Le Deist F, Mouly H, Metezeau P, Brechot C, et al. Overexpression of human cyclin A advances entry into S phase. Oncogene. 1995;10(8):1501–1509
  6. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992;11(3):961–971
  7. Faha B. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science. 1992;255(5040):87–90
  8. Bandara LR, Adamczewski JP, Hunt T, La Thangue NB. Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature. 1991;352(6332):249–251
  9. Mudryj M, Devoto SH, Hiebert SW, Hunter T, Pines J, Nevins JR. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell. 1991;65(7):1243–1253
  10. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science. 1993;262(5139):1572–1575
  11. Furihata M, Ishikawa T, Inoue A, et al.  Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 1996;2(10):1781–1785
  12. Volm M, Koomagi R, Mattern J, Stammler G. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer. 1997;75(12):1774–1778
  13. Chao Y, Shih YL, Chiu JH, Chau GY, Lui WY, Yang WK, et al. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 1998;58(5):985–990
  14. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjanen K, Kosma VM. Expression of cyclins A and D and p21 (waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer. 1999;80(12):2001–2007
  15. Handa K, Yamakawa M, Takeda H, Kimura S, Takahashi T. Expression of cell cycle markers in colorectal carcinoma (superiority of cyclin A as an indicator of poor prognosis). Int J Cancer. 1999;84(3):225–233
  16. Bukholm IR, Bukholm G, Nesland JM. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int J Cancer. 2001;93(2):283–287
  17. Aaltomaa S, Eskelinen M, Lipponen P. Expression of cyclin A and D proteins in prostate cancer and their relation to clinicopathological variables and patient survival. Prostate. 1999;38(3):175–182
  18. Huuhtanen RL, Blomqvist CP, Bohling TO, et al.  Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res. 1999;59(12):2885–2890
  19. Wang A, Yoshimi N, Suzui M, Yamauchi A, Tarao M, Mori H. Different expression patterns of cyclins A, D1 and E in human colorectal cancer. J Cancer Res Clin Oncol. 1996;122(2):122–126
  20. Davidson B, Risberg B, Berner A, et al.  Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications. Gynecol Oncol. 2001;83(2):249–256
  21. Mihara M, Shintani S, Nakahara Y, et al.  Overexpression of CDK2 is a prognostic indicator of oral cancer progression. Jpn J Cancer Res. 2001;92(3):352–360
  22. Kushner J, Bradley G, Young B, Jordan RC. Aberrant expression of cyclin A and B1 proteins in oral carcinoma. J Oral Pathol Med. 1999;28(2):77–81
  23. Jordan RC, Bradley G, Slingerland J. Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol. 1998;152(2):585–590
  24. Patel V, Jakus J, Harris CM, Ensley JF, Robbins KC, Yeudall WA. Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck. Int J Cancer. 1997;73(4):551–555
  25. Oliver RJ, MacDonald DG. Comparison of BrdU and cyclin A as markers of the S-phase in oral precancerous lesions. J Oral Pathol Med. 2000;29(9):426–431
  26. Thomson PJ, Soames JV, Booth C, O'Shea JA. Epithelial cell proliferative activity and oral cancer progression. Cell Prolif. 2002;35(Suppl1):110–120
  27. Betel-quid and areca-nut chewing. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyon, International Agency for Research on Cancer 1985;37:137–202.
  28. Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med. 1992;21(6):261–264
  29. Shiu MN, Chen TH, Chang SH, Hahn LJ. Risk factors for leukoplakia and malignant transformation to oral carcinoma (a leukoplakia cohort in Taiwan). Br J Cancer. 2000;82(11):1871–1874
  30. Kuo MY, Lin CY, Hahn LJ, Cheng SJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 1999;28(4):165–169
  31. Hermanek P, Sobin LH. TNM classification of malignant tumors. Heidelberg: Springer-Verlag; 1992;
  32. Kuo MY, Hsu HY, Kok SH, Kuo RC, Yang H, Hahn LJ, et al. Prognostic role of p27(Kip1) expression in oral squamous cell carcinoma in Taiwan. Oral Oncol. 2002;38(2):172–178
  33. Wang J, Zindy F, Chenivesse X, Lamas E, Henglein B, Brechot C. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene. 1992;7(8):1653–1656
  34. Kamb A, Gruis NA, Weaver-Feldhaus J. A cell cycle regulator potentially involved in the genesis of many tumor types. Science. 1994;264(5157):436–440
  35. Lotayef M, Wilson GD, Daley FM, Awwad HK, Shouman T. Aberrant expression of cyclin A in head and neck cancer. Br J Cancer. 2000;83(1):30–34

PII: S1368-8375(03)00007-1

doi: 10.1016/S1368-8375(03)00007-1

Oral Oncology
Volume 39, Issue 5 , Pages 476-482 , July 2003

Article Tools

* Image Usage & Resolution